Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial.
Laurie E McLouthFengmin ZhaoTaofeek K OwonikokoJosephine L FelicianoNisha A MohindraSuzanne E DahlbergJames L WadeGordan SrkalovicBradley W LashJoseph W LeachTiciana A LealCharu AggarwalDavid CellaSuresh S RamalingamLynne I WagnerPublished in: Cancer medicine (2020)
NCT01642251.
Keyphrases
- lymph node metastasis
- papillary thyroid
- phase ii
- patient reported
- open label
- small cell lung cancer
- squamous cell carcinoma
- clinical trial
- placebo controlled
- double blind
- phase iii
- randomized controlled trial
- machine learning
- type diabetes
- big data
- young adults
- squamous cell
- study protocol
- combination therapy
- adipose tissue